Cite
Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
MLA
Young, Lisa M., et al. “Field Study to Investigate the Effectiveness and Safety of a Novel Orally Administered Combination Drug Product Containing Milbemycin Oxime and Lotilaner (Credelio® Plus) for the Prevention of Heartworm Disease (Dirofilaria Immitis) in Client-Owned Dogs in the USA.” Parasites & Vectors, vol. 14, no. 1, Nov. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13071-021-04767-6.
APA
Young, L. M., Wiseman, S., Crawley, E., Wallace, K., & Snyder, D. E. (2021). Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA. Parasites & Vectors, 14(1), 1–8. https://doi.org/10.1186/s13071-021-04767-6
Chicago
Young, Lisa M., Scott Wiseman, Elizabeth Crawley, Kim Wallace, and Daniel E. Snyder. 2021. “Field Study to Investigate the Effectiveness and Safety of a Novel Orally Administered Combination Drug Product Containing Milbemycin Oxime and Lotilaner (Credelio® Plus) for the Prevention of Heartworm Disease (Dirofilaria Immitis) in Client-Owned Dogs in the USA.” Parasites & Vectors 14 (1): 1–8. doi:10.1186/s13071-021-04767-6.